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Abstract
Backgroud: Microdeletions at 19q13.2 are very rare. Only two cases have been previously described. Here we report a
2-year-2-month old boy with Diamond-Blackfan anemia, global developmental delay, cognitive impairments, distinctive
facial features, behavior problems, skeletal and genital dysplasia.
Case presentation: A de novo 1.6 Mb microdeletion at 19q13.2q13.31 was detected by chromosomal microarray
analysis. Haploinsufficiency of the RPS19 gene is known to cause Diamond-Blackfan anemia, other features in this
patient are likely due to the deletion of other candidate genes such as PAFAH1B3, ERF, LIPE and GSK3A.
Conclusion: The deletion detected in our patient overlapped and was significantly smaller than the ones previously
reported, which offered the opportunity to further define the critical region for this proposed contiguous gene
deletion syndrome.
Keywords: Microdeletion, 19q13.2, Diamond-Blackfan Anemia, Global developmental delay, Cognitive
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Background
Microdeletions at 19q13.2 have rarely been reported.
Cario [1] and Tentler [2] each reported a case with
microdeletion at 19q13.2 defined by FISH analysis re-
spectively, thus the sizes and boundaries of the deletions
were not precisely delineated. The clinical features of
the two patients included Diamond Blackfan Anemia
(DBA), global developmental delay, mental retardation,
distinctive facial features and skeletal malformations
[1, 2]. Haploinsufficiency of the RPS19 (OMIM 603474)
gene involved in the deletions is known to cause DBA.
DBA is a pure red-cell hypoplasia characterized by
defective erythroid progenitor maturation and normal
numbers and function of other haemopoietic cells [3–5].
It has been observed that patients with 19q13.2 microde-
letion involving the RPS19 gene presented with a more
complex clinical phenotype than those caused only by
sequence variants in RPS19 gene [1–7]. Tentler et al.
proposed that 19q13.2 deletion represented a novel
contiguous gene deletion syndrome [2]. Here, we report a
de novo 1.6 Mb microdeletion at 19q13.2q13.31 detected
by chromosomal microarray in a 2-year-2-month old boy
with many common features as reported in previous cases.
The deletion detected in our patient was smaller and bet-
ter defined by high resolution chromosomal microarray
analysis. This case offered the opportunity for defining the
critical region and discussing candidate genes associated
with different phenotypes.
Case presentation
The proband was the first child of healthy unrelated par-
ents and family history was unremarkable. Intrauterine
growth retardation and oligohydramnios was noticed by
ultrasound examination at 8 months of pregnancy.
Because of progressive intrauterine growth retardation
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(IUGR), a delivery by cesarean section was performed at
37 weeks of gestation. Birth weight was 3.1 kg, length
47 cm (<−2SD) and head circumference 34 cm. Apgar
scores were all 8. Feeding difficulty was noted at all
times. At the age of 9 months he was referred to a
pediatric clinic because of pallor. Hemoglobin concen-
tration was 64 g/l and no reticulocytes were detected in
peripheral blood. Bone marrow aspirate showed a
selective decrease in erythroid precursors but otherwise
normal cellularity. Hemoglobin concentration was recov-
ered from 64 to 106 g/l after corticosteroid treatment.
The proband was 2 years 2 months old at the time of
molecular evaluation. His weight was 9.9 kg (<−2SD),
height 78 cm (<−3SD), and head circumference 47.5 cm,
which indicated persistent failure to thrive. The develop-
mental milestones were delayed: he raised his head at
7 months, sat alone at 1 year and could not independ-
ently walk yet. Language development was significantly
delayed and he had almost complete absence of speech.
He had moderate cognitive impairments. His distinctive
facial features were characterized by cranial deformities,
mild craniosynostosis, broad forehead, auricle dysplasia,
arched and sparse eyebrows, hypertelorism, nystagmus
and strabismus, broad nose with depressed nasal bridge,
thick lips, teeth dysplasia, micrognathia, open-mouthed
expression and drooling. He had skeletal abnormality in-
cluding rib protrusion and kyphosis, but with normal
level of calcium, phosphorus and alkaline phosphatase
(Fig. 1). His abnormal behavior included mild self-
mutilation, fingers biting, tongue stretching, anxiety and
hyperactivity. He was insensitive to pain. Severe hypo-
tonia and sleep disorders were present. Micropenis,
small testes and anal fissure were detected. He had
gastrointestinal dysfunction and suffered from frequent
diarrhea. He would have high body temperature at night
and return to normal at daylight spontaneously. Brain
MRI, ultrasound and X-ray examinations for heart and
lungs were all normal.
Methods
Chromosome karyotype analysis
Cytogenetic investigations (GTG banding) on 20
metaphases obtained from PHA-stimulated peripheral
lymphocytes of the patient were performed following
standard protocols.
Fig. 1 The proband at 2-year-2-month age. Note cranial deformities, mild craniosynostosis, broad forehead, auricle dysplasia, hypertelorism, strabismus,
broad nose with depressed nasal bridge, thick lips, micrognathia and open-mouthed expression, rib protrusion and kyphosis
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Chromosomal microarray analysis
Chromosomal microarray analysis was performed for
the patient and both parents by Affymetrix Cytoscan
HD Array (Affymetrix, USA). Genomic DNA was
extracted from peripheral blood using a commercial
kit (Qiagen). The labeling and hybridization pro-
cedures were performed following manufacturer’s in-
structions. The raw data of chromosomal microarray
was analyzed by Affymetrix Chromosome Analysis
Suite Software.
Fig. 2 Affymetrix cytoscan HD array analysis including weighted log2 ratio (upper), copy number state (middle) and allele peaks (lower) are
shown for chromosome 19. The result shows microdeletion at 19q13.2q13.31. The genomic coordinates (hg19): chr19:42,306,042-43,906,653. The
microdeletion region is denoted by a red bar
Fig. 3 Top panel shows a genome view of all deletion cases (red colored custom tracks) relative to the genomic coordinates at 19q13.2q13.31
region, extracted from Human Genome Build 37 (hg19). Blue block diagram represents critical region of 19q13.2. Bottom panel shows the
zoomed-in 19q13.2 critical region encompassing candidate genes
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Confirmation of 19q13.2q13.31deletion
The deletion was further confirmed using quantitative
real-time PCR analysis. Primer sequences and descrip-
tions were included in Additional file 1: Table S1.
Results
Standard chromosome analysis of peripheral blood by GTG
banding was normal (data not shown). A 1.6 Mb microde-
letion at 19q13.2q13.31 (chr19:42,306,042-43,906,653) was
detected by chromosomal microarray analysis (Fig. 2). Par-
ental chromosomal microarray analysis were normal. Thus,
the proband carried a de novo copy number variant. The
deletion was further confirmed by quantitative real-time
PCR analysis (data not shown).
Discussion and conclusion
Microdeletions at 19q13.2 are very rare. So far, only two
cases carrying a microdeletion at 19q13.2 have been
reported who share similar clinical features including
Diamond-Blackfan anemia, global developmental delay,
skeletal abnormalities and intellectual disability. Both cases
were detected by FISH analysis and the relative break-
points and sizes estimation of the deletions were deter-
mined, whereas candidate genes except for RPS19 gene in
this interval responsible for the complex clinical features
of the patients were not identified [1, 2]. Our patient re-
ported here carries a de novo 1.6 Mb microdeletion at
19q13.2q13.31 uncovered by high resolution chromosomal
microarray analysis and no other clinical significant copy
Table 1 Clinical features observed in patients with 19q13.2 deletion
Phenotypic characteristic Our patient Cario et al. Tentler et al.
Sex Male Male Male
Age 2 years 2 months 13 months 12 years
Size of the deletion (Mb) 1.6 Mb about 3.0 Mb about 3.2 Mb
Genomic location chr19:42306042-43906653 19q13.2q13.31 19q13.2q13.31
Methods microarray interphase FISH fibre-FISH
Diamond-Blackfan Anemia + + +
Feeding difficulties + NR NR
IUGR + NR NR
Global developmental delay
Growth delay (short stature) + + +
Delayed motor development + + +
Language delay + + +
Cognitive impairments + + +
Craniofacial features
Macrocephaly - + +
Cranial deformities + + +
Broad forehead + + NR
Auricle dysplasia + + NR
Hypertelorism + + NR
strabismus + + NR
Broad nose with depressed nasal bridge + + NR
Thick lips + + NR
Teeth dysplasia + NR NR
Open-mouthed expression + + NR
Drooling + + NR
Skeletal abnormalities + + +
Genital anomalies + (small testes) + (cryptorchidism) NR
Hypotonia + + NR
Behavior problems + + NR
Body temperature dysregulation + NR NR
IUGR intrauterine growth retardation, NR not reported
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number variants are detected. The positions and sizes of
three cases are delineated in Fig. 3. The clinical presenta-
tions in all three cases are summarized in Table 1.
Haploinsufficiency of the RPS19 gene is responsible
for the Diamond-Blackfan anemia phenotype in these
patients. RPS19 deletion is not likely to cause other
features observed in these individuals since none of the
patients with DBA caused by RPS19 gene point
mutations has developmental delay, intellectual disability
or dysmorphism features [5–7]. Furthermore, a girl re-
ported to carry a de novo balanced translocation t(X;19)
(p21;q13) which interrupted the RPS19 gene also had
normal development without skeletal malformations
[3, 4]. These findings further suggested that other genes
at 19q13.2 locus contributed to other clinical features
observed in these patients.
Based on this notion, we analyzed all genes involved in
the deleted interval detected in our patient in Additional
file 2: Table S2. And we identified several candidate genes
that could explain the additional features seen in our
patient. The PAFAH1B3 (OMIM 603074) gene maps in
19q13.2 region. Mutations or deletions of PAFAH1B1 gene
result in Miller-Dieker syndrome characterized by lissence-
phaly, severe intellectual disability, developmental delay,
distinctive facial features, seizures, hypotonia and feeding
difficulties. PAFAH1B1 is a subunit of a brain platelet-
activating factor acetylhydrolase (PAFAH1B) where it
forms a heterotrimeric complex with two hydrolase sub-
units, referred to as 29 kDa (PAFAH1B3) and 30 kDa
(PAFAH1B2). In the brain, PAFAH1B complex regulates
the level of platelet activating factor, which is thought to be
involved in neuronal migration essential for normal brain
development and function [8–10].
Haploinsufficiency of ERF (OMIM 611888) gene in-
volved in this interval leads to complex craniosynostosis
recognized by multiple-suture synostosis, craniofacial
dysmorphism, Chiari malformation, behavior problems
and language delay [11, 12].
Among other genes in this interval, we identified the
LIPE (OMIM 151750) and GSK3A (OMIM 606784) as
candidate genes. Animal model shows that hormone
sensitive lipase encoded by LIPE gene is a multifunc-
tional fatty acyl esterase that causes male infertility and
decreased testes weight and also plays an important role
in the function of adipocytes, pancreatic-cells, and ad-
renal cortical cells [13–15]. Glycogen synthase kinase 3
(GSK3), encoded by GSK3A and GSK3B genes, is shown
to be expressed ubiquitously in all mammalian tissues
and is also essential for normal sperm function required
for male fertility [16, 17]. Furthermore GSK3 is impli-
cated to be associated with a variety of diseases includ-
ing mood disorders, Alzheimer disease, diabetes and
cancer, and plays a role in embryo development as well
[17–19]. Taken together, these candidate genes involved
in 19q13.2 region could explain the complex clinical
phenotype observed in our patient.
In conclusion, we report a de novo microdeletion at
19q13.2q13.31 in a patient with DBA, global develop-
mental delay, cognitive impairments, facial dysmorph-
ism, behavior problems, skeletal and genital dysplasia.
Our patient exhibited strikingly similar clinical pheno-
types among those patients with 19q13.2 microdeletions.
Haploinsufficiency of the RPS19 is the cause of DBA and
several candidate genes responsible for other clinical
features are identified in this interval, which further sug-
gests a novel contiguous gene deletion syndrome and
the critical region at 19q13.2 locus is defined as well.
Additional files
Additional file 1: Table S1. Primers information. (DOCX 23 kb)
Additional file 2: Table S2. All genes in the deleted interval detected
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